Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune response after initiation of a personalized cancer vaccine.
source https://www.sciencedaily.com/releases/2025/02/250205130931.htm
AMD fixes bug that lets hackers load malicious microcode patches
-
AMD has released mitigation and firmware updates to address a
high-severity vulnerability that can be exploited to load malicious CPU
microcode on unpatch...
5 hours ago
No comments:
Post a Comment